Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Treatment procedure
| Neoadjuvant | Adjuvant | P-value | |
|---|---|---|---|
| Number of gemcitabine plus cisplatin cycles | |||
| Median | 4.0 | 4.0 | 0.166 |
| Mean | 3.80 | 3.53 | 0.073 |
| Range | 2–4 | 1–4 | |
| Relative dose intensity (%) | |||
| Gemcitabine | 82 | 78 | 0.460 |
| Cisplatin | 95 | 82 | 0.073 |
| Treatment duration, days | |||
| Median | 134.0 | 150.0 | 0.016 |
| Mean | 131.7 | 153.4 | 0.023 |
| Range | 62–195 | 94–246 | |
| Follow-up, months | 0.377 | ||
| Median | 25.1 | 33.8 | |
| Range | 3.4–58.4 | 6.8–64.9 |
